BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23598928)

  • 1. Itraconazole as 'bridge therapy' to anti-IgE in a patient with severe asthma with fungal sensitisation.
    Pizzimenti S; Bussolino C; Badiu I; Rolla G
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23598928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe asthma with fungal sensitization.
    Agarwal R
    Curr Allergy Asthma Rep; 2011 Oct; 11(5):403-13. PubMed ID: 21789577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IgE therapy for allergic bronchopulmonary aspergillosis.
    Homma T; Kurokawa M; Matsukura S; Yamaguchi M; Adachi M
    J Microbiol Immunol Infect; 2016 Jun; 49(3):459-63. PubMed ID: 24291616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal sensitisation in severe asthma is associated with the identification of Aspergillus fumigatus in sputum.
    Farrant J; Brice H; Fowler S; Niven R
    J Asthma; 2016 Sep; 53(7):732-5. PubMed ID: 27043956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis.
    Pasqualotto AC; Powell G; Niven R; Denning DW
    Respirology; 2009 Nov; 14(8):1121-7. PubMed ID: 19909460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
    Wolf BL; Johnson A
    J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
    Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of omalizumab in severe asthma with fungal sensitisation: a case report.
    Di Stefano F; Cinti B; Antonicelli L
    Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):56-9. PubMed ID: 24702879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of recombinant Aspergillus fumigatus antigens in diagnosing Aspergillus sensitisation among asthmatics.
    Muthu V; Singh P; Choudhary H; Dhooria S; Sehgal IS; Prasad KT; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
    Mycoses; 2020 Sep; 63(9):928-936. PubMed ID: 32490571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
    Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
    BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
    Altman MC; Lenington J; Bronson S; Ayars AG
    J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.
    Lin RY; Sethi S; Bhargave GA
    J Asthma; 2010 Oct; 47(8):942-5. PubMed ID: 20831464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients.
    Tanimoto H; Fukutomi Y; Yasueda H; Takeuchi Y; Saito A; Watai K; Sekiya K; Tsuburai T; Asano K; Taniguchi M; Akiyama K
    Clin Exp Allergy; 2015 Dec; 45(12):1790-800. PubMed ID: 26118958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of effective readministration of itraconazole for recurrent allergic bronchopulmonary aspergillosis].
    Uji M; Sugama Y; Nishida K; Matsushita H
    Nihon Kokyuki Gakkai Zasshi; 2005 Jul; 43(7):412-6. PubMed ID: 16050467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
    Evans MO; Morris MJ; Coop CA; Evans SE
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):250-1. PubMed ID: 26162570
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
    Voskamp AL; Gillman A; Symons K; Sandrini A; Rolland JM; O'Hehir RE; Douglass JA
    J Allergy Clin Immunol Pract; 2015; 3(2):192-9. PubMed ID: 25640470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.